Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Induced pluripotent stem cells in the inherited cardiomyopathies: From disease mechanisms to novel therapies.

Trends in cardiovascular medicine - 1 Nov 2016

Ross Samantha Barratt, Fraser Stuart T, Semsarian Christopher

Abstract excerpt

Inherited cardiomyopathies lead to diverse clinical outcomes including heart failure, arrhythmias, and sudden death. Mutations in over 100 genes have been implicated in the pathogenesis of genetic heart diseases, including the main inherited cardiomyopathies, such as hypertrophic, dilated, and arrhythmogenic right ventricular cardiomyopathies. Understanding how these gene mutations lead to clinical disease and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiomyopathies
Share to Cell Lineage
Share to Heredity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Induced Pluripotent Stem Cells

Share to Myocytes, Cardiac

Share to Regeneration

Share to Stem Cell Transplantation

Share to Transplantation, Autologous

Source

Identifiers

PMID: 27296521
DOI: 10.1016/j.tcm.2016.05.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Induced pluripotent stem cells in the inherited cardiomyopathies: From disease mechanisms to novel therapies.PMID 27296521Read ↗

Untangling the Biology of Genetic Cardiomyopathies with Pluripotent Stem Cell Disease Models.Semantic proximity Read ↗

Modelling inherited cardiac disease using human induced pluripotent stem cell-derived cardiomyocytes: progress, pitfalls, and potential.Semantic proximity Read ↗

Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic CardiomyopathiesSemantic proximity Read ↗

Concise Review: Cardiac Disease Modeling Using Induced Pluripotent Stem CellsSemantic proximity Read ↗

Induced pluripotent stem-cell-derived cardiomyocytes: cardiac applications, opportunities, and challenges.Semantic proximity Read ↗

Human iPSC-Derived Cardiomyocytes for Investigation of Disease Mechanisms and Therapeutic Strategies in Inherited Arrhythmia Syndromes: Strengths and LimitationsSemantic proximity Read ↗

Induced Pluripotent Stem Cells Technology and Cardiomyocyte Generation: Progress, Uncertainties and Challenges in the Biological Features and Clinical ApplicationsSemantic proximity Read ↗

Inherited cardiac diseases, pluripotent stem cells, and genome editing combined—the past, present, and futureSemantic proximity Read ↗

Targeted Therapies in Genetic Dilated and Hypertrophic Cardiomyopathies: From Molecular Mechanisms to Therapeutic Targets. A Position Paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)Semantic proximity Read ↗

Disease Modeling and Disease Gene Discovery in Cardiomyopathies: A Molecular Study of Induced Pluripotent Stem Cell Generated Cardiomyocytes.Semantic proximity Read ↗

Modeling Inherited Cardiac DisordersSemantic proximity Read ↗

Induced Pluripotent Stem Cells in Congenital Long QT Syndrome: Research Progress and Clinical ApplicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.